Thursday, October 8, 2009

6:30am - 8:00am	Breakfast Symposium High Dose Insulin Therapy for Patients with T2DM and Severe Insulin Resistance: Comprehensive Clinical Update and Expert Recommendations Lawrence Blonde, MD; Wendy Lane, MD; Jay Skyler, MD Supported by an educational grant from Eli Lilly and Company
6:30am – 8:00am	Breakfast Symposium Hypertension and CV Risk Reduction: The Role of New Generation Beta Blockade Thomas Giles, MD; R. Preston Mason, PhD; Raymond Townsend, MD Supported by an educational grant from Forest Laboratories
8:10am – 8:30am	Opening Remarks Global Cardiometabolic Risk 2009: Where We Are Today Robert Eckel, MD; Richard Nesto, MD
8:30am – 9:15am	Keynote Session New Insights into the Pathogenesis of Atherothrombosis Peter Libby, MD
9:15am – 10:30am	Late - Breaking Clinical Trials: Implications for Clinical Practice Moderator: Richard Nesto, MD Panelists: Christie Ballantyne, MD; Christopher Cannon, MD; Keith Ferdinand, MD; Jay Skyler, MD
10:30am – 11:00am	Morning Break/Exhibit Hall
11:00am - 12:00pm	Obesity Management: Diet, Lifestyle, Pharmacotherapy, and Surgery Moderator: Robert Eckel, MD How Much and What Type of Exercise for What Benefit? William Kraus, MD Obesity Management: What Diet Should You Recommend? Anne Wolf, RD, MS
12:00pm – 1:45pm	Lunch Symposium Advances in the Clinical Management of Obesity: Implications of Therapies in Late-Stage Development Caroline Apovian, MD; Louis Aronne, MD; Kenneth Fujioka, MD Supported by an educational grant from Orexigen Therapeutics, Inc.
12:00pm – 1:45pm	Lunch Symposium Advances in Dual Anti-Platelet Therapy: Optimizing Anti-Thrombotic Therapy in Patients with ACS Jeffrey Anderson, MD; Christopher Cannon, MD; Marc Sabatine, MD Supported by an educational grant from Daiichi Sankyo, Inc. and Eli Lilly and Company
2:00pm – 3:00pm	Obesity Management: Diet, Lifestyle, Pharmacotherapy, and Surgery Moderator: Robert Eckel, MD Lifestyle Modification for Adults, Adolescents, and Children Rebecca Reeves, DrPH, RD Pharmacotherapy for the Management of Obesity Caroline Apovian, MD
3:00pm – 3:30pm	Afternoon Break/Exhibit Hall
3:30pm – 5:00pm	Obesity Management: Diet, Lifestyle, Pharmacotherapy, and Surgery Moderator: Robert Eckel, MD Bariatric Surgery: A Cure for T2DM? Matthew Hutter, MD Obesity Panel Discussion Moderator: Robert Eckel, MD Panelists: Matthew Hutter, MD; William Kraus, MD; Rebecca Reeves, DrPH, RD; Anne Wolf, RD, MS
5:00pm	Closing Remarks Robert Eckel, MD
5:00pm – 6:30pm	Welcome Reception
6:30pm – 8:30pm	Dinner Symposium Glucose Control and Beyond: The Multiple Roles of Incretin Therapy in the Management of Type 2 Diabetes and Cardiometabolic Risk Lawrence Blonde, MD; Richard Pratley, MD; Bernard Zinman, MD Supported by an educational grant from Novo Nordisk

Friday, October 9, 2009

6:30am - 8:00am	Breakfast Symposium Targeting the Endothelin Pathway: Novel Strategies to Delay Disease Progression and Improve Outcomes in Pulmonary Arterial Hypertension Michael J. Landzberg, MD; Ioana Preston, MD; Jeffrey Sager, MD Supported by an educational grant from Actelion Pharmaceuticals US, Inc.
6:30am – 8:00am	Breakfast Symposium The Emerging Role of Biomarker Panel Assays in Diabetes Prevention: Identifying High-Risk Patients Before It’s Too Late Richard Bergman, PhD; Ralph DeFronzo, MD; Darren McGuire, MD; Jay Skyler, MD, MACP Supported by an unrestricted education grant from Tethys Bioscience
8:00am – 8:15am	Opening Remarks Jay Skyler, MD
8:15am – 9:00am	Keynote Session The Skinny on Body Fat C. Ronald Kahn, MD
9:00am – 9:30am	Deficient Insulin Secretion in Type 2 Diabetes Jerry Palmer, MD
9:30am – 10:30am	Diabetes Management Across the Lifespan Moderator: Jay Skyler, MD Diabetes Management Across the Lifespan: Glycemic Control in Children with T2DM Silva Arslanian, MD
10:00am – 10:30am	Morning Break/Exhibit Hall
10:30am – 12:00pm	Diabetes Management Across the Lifespan Moderator: Jay Skyler, MD Diabetes Management Across the Lifespan: Glycemic Control in Adults with T2DM Harold Lebovitz, MD Diabetes Management Across the Lifespan: Glycemic Control in the Elderly Richard Pratley, MD Diabetes Panel Discussion Moderator: Jay Skyler, MD Panelists: Silva Arslanian, MD; Ralph DeFronzo, MD; Harold Lebovitz, MD; Richard Pratley, MD
12:15pm – 1:45pm	Lunch Symposium New Treatment Paradigms for Comprehensive Cardiometabolic Risk Reduction: The Role of GLP-1 Receptor Agonists in the Management of T2DM, Obesity, Hypertesion & Dyslipidemia Ralph DeFronzo, MD; David Kendall, MD; Anne Peters, MD Supported by an educational grant from Amylin/Lilly
12:15pm – 1:45pm	Lunch Symposium Clinical Dilemmas in Managing the Hypertensive Patient with Osteoarthritis Michael Farkouh, MD; Alan Gradman, MD; R. Preston Mason, PhD; William White, MD Supported by an educational grant from NicOx, Inc.
2:00pm – 2:30pm	The Relationship Between Insulin Resistance and Atherosclerotic Cardiovascular Disease Ralph DeFronzo, MD
2:30pm – 3:00pm	CKD: A CHD Equivalent? Robert Toto, MD
3:00pm – 3:30pm	Afternoon Break/Exhibit Hall
3:30pm – 4:00pm	Managing Resistant Hypertension in Clinical Practice Henry R. Black, MD
4:00pm – 5:00pm	Cardiometabolic Risk: A Link to Other Important Conditions Robert Eckel, MD; Richard Nesto, MD
5:00pm	Closing Remarks Jay Skyler, MD
6:00pm – 8:00pm	Dinner Symposium Global Cardiometabolic Risk Reduction: Targeting the Multiple Mechanisms Underlying Type 2 Diabetes, Dyslipidemia, and Hypertension Om Ganda, MD; Ronald Goldberg, MD; Joseph Izzo, Jr., MD; Suzanne Oparil, MD Supported by an educational grant from Daiichi Sankyo, Inc.

Saturday, October 10, 2009